Non-restrictive satiating intervention for Weight Loss

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Weight Loss+3 More
Non-restrictive satiating intervention - Other
Eligibility
18 - 65
All Sexes
What conditions do you have?
Select

Study Summary

This trial is evaluating the effect of a non-restrictive, satiating intervention on appetite control, weight loss and maintenance in men and women living with obesity, compared to a conventional restrictive intervention and a control group.

Eligible Conditions
  • Weight Loss
  • Weight Maintenance
  • Appetite Control

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

4 Primary · 8 Secondary · Reporting Duration: 18 months

18 months
Anxiety
Blood pressure
Depression Symptoms
Diet satisfaction
Eating Behaviours
Lipids (HDL-cholesterol, LDL-cholesterol, triglycerides, total cholesterol)
Stress
6 months
Body composition
Body weight
Energy intake
Hunger/Satiety
neurobehavioural variables

Trial Safety

Safety Progress

1 of 3

Trial Design

3 Treatment Groups

Conventional restrictive intervention + non-restrictive satiating intervention
1 of 3
Non-restrictive satiating intervention
1 of 3
Minimal healthy guidelines
1 of 3
Experimental Treatment
Non-Treatment Group

234 Total Participants · 3 Treatment Groups

Primary Treatment: Non-restrictive satiating intervention · Has Placebo Group · N/A

Conventional restrictive intervention + non-restrictive satiating intervention
Other
Experimental Group · 1 Intervention: Conventional restrictive intervention + non-restrictive satiating intervention · Intervention Types: Other
Non-restrictive satiating intervention
Other
Experimental Group · 1 Intervention: Non-restrictive satiating intervention · Intervention Types: Other
Minimal healthy guidelines
Other
PlaceboComparator Group · 1 Intervention: Control group · Intervention Types: Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 18 months

Who is running the clinical trial?

University of OttawaOTHER
176 Previous Clinical Trials
246,667 Total Patients Enrolled
4 Trials studying Weight Loss
416 Patients Enrolled for Weight Loss
Laval UniversityLead Sponsor
385 Previous Clinical Trials
164,145 Total Patients Enrolled
3 Trials studying Weight Loss
153 Patients Enrolled for Weight Loss

Eligibility Criteria

Age 18 - 65 · All Participants · 3 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 19th, 2021

Last Reviewed: October 10th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.